Journal of Gastroenterology

Article	Citations
Managing radiation safety and protection in gastroenterology in Japan: insights from the REX-GI study	260
Ratio of submucosal thickness to total bowel wall thickness as a new sonographic parameter to estimate endoscopic remission of ulcerative colitis	190
Corynoline protects chronic pancreatitis via binding to PSMA2 and alleviating pancreatic fibrosis	147
Revisiting the relationship between thyroid function and metabolic dysfunction-associated steatotic liver disease in the era of resmetirom	106
Correlation between mismatch repair and survival of patients with gastric cancer after 5-FU-based adjuvant chemotherapy	87
High-risk population of progressive hepatic fibrosis in chronic hepatitis B patients on antiviral therapy	80
Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy	68
Clinical features and oncological outcomes of intestinal cancers associated with ulcerative colitis and Crohn’s disease	61
Non-alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism	55
Three-dimensional chromatin landscapes in hepatocellular carcinoma associated with hepatitis B virus	48
Induction of ferroptosis by photodynamic therapy and enhancement of antitumor effect with ferroptosis inducers	48
Alpha-fetoprotein combined with initial tumor shape irregularity in predicting the survival of patients with advanced hepatocellular carcinoma treated with immune-checkpoint inhibitors: a retrospectiv	44
Artificial intelligence (AI) models for the ultrasonographic diagnosis of liver tumors and comparison of diagnostic accuracies between AI and human experts	44
Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma	42
Novel subharmonic-aided pressure estimation for identifying high-risk esophagogastric varices	41
STING and liver disease	40
Successful induction of human chemically induced liver progenitors with small molecules from damaged liver	38
Association between homologous recombination deficiency and time to treatment failure to platinum-based chemotherapy for pancreatic cancer by using the C-CAT database	35
Predictive factors for the progression of primary localized stage small-bowel follicular lymphoma	34
Considerations for evaluating antibiotic prophylaxis in cirrhotic patients with upper gastrointestinal bleeding in real-world data	29
Reply to: Minocycline versus tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori rescue treatment: a multicentre, randomized controlled trial	29
Clinical factors to predict changes of esophagogastric varices after sustained viral response with direct-acting antiviral therapy	28
Associations between excessive supragastric belching and esophageal reflux factors in patients with PPI-refractory GERD in Japan	28
Induction therapy with hepatic arterial infusion chemotherapy enhances the efficacy of lenvatinib and pd1 inhibitors in treating hepatocellular carcinoma patients with portal vein tumor thrombosis	27
Clinical practice guidelines for duodenal cancer 2021	27

Immunity in digestive diseases: new drugs for inflammatory bowel disease treatment—insights from Phase II and III trials	27
The absence of warfarin treatment and situs inversus are associated with the occurrence of hepatocellular carcinoma after Fontan surgery	27
Clinicopathological features and prognosis of primary small bowel adenocarcinoma: a large multicenter analysis of the JSCCR database in Japan	25
Alcohol-associated liver disease increases the risk of muscle loss and mortality in patients with cirrhosis	25
Trends of hepatitis B virus genotype distribution in chronic hepatitis B patients in Japan	25
Persistent body-weight change on achalasia and peroral endoscopic myotomy: a multicenter cohort study	24
Current status and trends in ERCP and post-ERCP pancreatitis in Japan: a nationwide observational study	24
Correction: Fungal mycobiome dysbiosis in choledocholithiasis concurrent with cholangitis	24
Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 2021	24
Acknowledgements	24
Body mass index and survival among patients with advanced biliary tract cancer: a single-institutional study with nationwide data-based validation	23
A study for every second day administration of vonoprazan for maintenance treatment of erosive GERD (ESD von GERD): a multicenter randomized cross-over study	23
Expert consensus on vaccination in patients with inflammatory bowel disease in Japan	22
Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey	21
Is it necessary for endoscopic surveillance for achalasia patients?	20
What is the appropriate method of pathological specimen collection for cholangiocarcinoma detection in primary sclerosing cholangitis?	20
Evaluation of cholecystectomy in older individuals using real-world data: a multilevel analysis based on a nationwide administrative database in Japan	20
Ursodeoxycholic acid for the prevention of gallstones and subsequent cholecystectomy after bariatric surgery: a meta-analysis of randomized controlled trials	20
Circulating miR-485-3p as a biomarker for VEGF-associated therapeutic response to atezolizumab plus bevacizumab in hepatocellular carcinoma	19
Targeting autophagy as a therapeutic strategy against pancreatic cancer	19
Nationwide cohort study identifies clinical outcomes of angioectasia in patients with acute hematochezia	19
Proton pump inhibitor use and risk of pneumonia: a self-controlled case series study	19
Utility of artificial intelligence with deep learning of hematoxylin and eosin-stained whole slide images to predict lymph node metastasis in T1 colorectal cancer using endoscopically resected specime	19
Real-world efficacy and safety of glecaprevir/pibrentasvir in Japanese adolescents with chronic hepatitis C: a prospective multicenter study	18
Discrepancies in reported gastrointestinal symptoms in Japanese hospitalized patients with COVID-19	17
Frequency of lymph node metastasis according to tumor location in clinical T1 early gastric cancer: supplementary analysis of the Japan Clinical Oncology Group study (JCOG0912)	17
Cancer pathways in serrated polyposis syndrome: is conventional more crucial than serrated?	17
“Pathologist-independent” strategy for T1 colorectal cancer after endoscopic resection	17
RTP4 silencing provokes tumor-intrinsic resistance to immune checkpoint blockade in colorectal cancer	17
Clinical trajectory of intraductal papillary mucinous neoplasms progressing to pancreatic carcinomas during long-term surveillance: a prospective series of 100 carcinoma cases	17
Interim analysis of a multicenter registry study of COVID-19 patients with inflammatory bowel disease in Japan (J-COSMOS)	17
Reply to “Considerations for evaluating antibiotic prophylaxis in cirrhotic patients with upper gastrointestinal bleeding in real-world data”	17
Gastric cancer and genomics: review of literature	17
Current status of primary liver cancer and decompensated cirrhosis in Japan: launch of a nationwide registry for advanced liver diseases (REAL)	17
Reply to “promising modality for severe ulcerative colitis: infliximab and plant-based diet as first-line (IPF) therapy”	16
Characteristics, outcomes, and risk factors of surgery for acute lower gastrointestinal bleeding: nationwide cohort study of 10,342 hematochezia cases	15
Identification of novel plasma proteins as promising noninvasive biomarker for early diagnosis and surveillance of pancreatic ductal adenocarcinoma	15
The epidemiology of rare types of hepatobiliary and pancreatic cancer from national cancer registry	15
Effect of blood product transfusion on the prognosis of patients undergoing hepatectomy for hepatocellular carcinoma: a propensity score matching analysis	15
Correction: Partial splenic embolization combined with endoscopic therapies and vasoconstrictive drugs reduces rebleeding in cirrhosis patients with acute variceal bleeding and hypersplenism: a multic	15
Impact of ursodeoxycholic acid treatment on Fontan-associated liver disease	15
Molecular imaging of gastrointestinal stromal tumor using anti-c-KIT antibody and its fragments	14
Risk of gastric and oesophageal adenocarcinomas following discontinuation of long-term proton-pump inhibitor therapy	14
Standard versus delayed initiation of S-1 adjuvant chemotherapy after surgery for pancreatic cancer: a secondary analysis of a nationwide cohort by the Japan Pancreas Society	14
Acute kidney injury development is associated with mortality in Japanese patients with cirrhosis: impact of amino acid imbalance	14
Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation	14
Physician–patient communication affects patient satisfaction in treatment decision-making: a structural equation modelling analysis of a web-based survey in patients with ulcerative colitis	14
A review on the current status and definitions of activity indices in inflammatory bowel disease: how to use indices for precise evaluation	13
Correction to: Composite detection rate as an upper gastrointestinal endoscopy quality measure correlating with detection of neoplasia	13
Efficacy of endoscopic ultrasound-guided tissue acquisition for solid pancreatic lesions 20 mm or less in diameter suspected as neuroendocrine tumors or requiring differentiation	13

The role of stromal BMP/CXCL12 signaling axis in serrated polyp development	13
Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: a final report of safety and effectiveness data	13
Correction: Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer	13
Serum zinc levels as predictors of covert hepatic encephalopathy in patients with liver cirrhosis	12
Renal manifestations in inflammatory bowel disease: a systematic review	12
Adjuvant immune checkpoint inhibitors associated with higher recurrence-free survival in postoperative hepatocellular carcinoma (PREVENT): a prospective, multicentric cohort study	12
Treatment strategy after noncurative endoscopic resection for early gastric cancers in patients aged ≥ 85 years: a multicenter retrospective study in a highly aged area of Japan	12
Efficacy, tolerability, and safety of oral sulfate tablet versus 2 L-polyethylene glycol/ascorbate for bowel preparation in older patients: prospective, multicenter, investigator single-blinded, rando	12
Characteristics of colorectal neuroendocrine tumors in patients prospectively enrolled in a Japanese multicenter study: a first report from the C-NET STUDY	12
The external validation of Dallas Steatosis Index among Asian population: a useful tool for metabolic dysfunction-associated steatotic liver disease identification and prevention	12
Prevalence of colonoscopy in Japan using a large-scale health claims data compared to esophagogastroduodenoscopy	12
Novel scale for evaluating the therapeutic efficacy of per-oral endoscopic myotomy in achalasia	11
Publisher Correction: Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study	11
Correction: Nrf2/ASPM axis regulated vasculogenic mimicry formation in hepatocellular carcinoma under hypoxia	11
Development of a novel oncolytic adenovirus controlled by CDX2 promoter for esophageal adenocarcinoma therapy	11
Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of pancreatic cancer	11
Clinical outcome after cessation of nucleos(t)ide analog treatment in chronic hepatitis B patients who achieved HBsAg seroclearance	11
Definitive-dose adjuvant radiotherapy following endoscopic submucosal dissection for superficial esophageal cancer	11
HBeAg-positive patients with HBsAg  < 100 IU/mL and negative HBV RNA have lower risk of virological relapse after nucleos(t)ide analogues cessation	11
Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study	11
Acknowledgements	11
Proposal of discontinuation criteria of atezolizumab plus bevacizumab after curative conversion therapy for unresectable early-to-intermediate-stage hepatocellular carcinoma: a multicenter proof-of-co	11
Activating KRAS and GNAS mutations in heterotopic submucosal glands of the stomach	10
The antiferroptotic effect of indigo on ulcerative colitis	10
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis	10
Serum IL-6 concentration is a useful biomarker to predict the efficacy of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma	10
Correction to: Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy	10
Optimal direct oral anticoagulant for upper gastrointestinal endoscopic submucosal dissection	10
Response to letter to the editor regarding: “Alcohol-associated liver disease increases the risk of muscle reduction and mortality in patients with cirrhosis”	10
Nrf2/ASPM axis regulated vasculogenic mimicry formation in hepatocellular carcinoma under hypoxia	10
Pro- and anti-inflammatory roles of interleukin (IL)-33, IL-36, and IL-38 in inflammatory bowel disease	10
Anti-integrin αvβ6 autoantibodies in patients with primary sclerosing cholangitis	10
Multicenter prospective in vivo study of an endocytoscope system (ECS) for superficial esophageal cancer	10
Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer	10
Comprehensive aptamer-based screen of 1317 proteins uncovers improved stool protein markers of colorectal cancer	10
Reply to: “COVID-19-associated liver injury (COVALI): role of hepatologists”	10
Reply to “Discrepancies in reported gastrointestinal symptoms in Japanese hospitalized patients with COVID-19”	10
A systematic review of the prevalence of germline pathogenic variants in patients with pancreatic cancer	9
Mutant GNAS limits tumor aggressiveness in established pancreatic cancer via antagonizing the KRAS-pathway	9
FGFR2 fusions assessed by NGS, FISH, and immunohistochemistry in intrahepatic cholangiocarcinoma	9
Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus	9
A proposed risk assessment score for gastrointestinal stromal tumors based on evaluation of 19,030 cases from the National Cancer Database	9
Letter to "The potential of an artificial intelligence for diagnosing MRI images in rectal cancer: multicenter collaborative trial"	9
Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study	9
Growing evidence on the highly sensitive iTACT assay of hepatitis B core-related antigen for predicting hepatitis B virus reactivation	9
Estimating cancer risk in immune-mediated inflammatory diseases exposed to varying doses of tumour necrosis factor inhibitors	9
The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer	9
Acknowledgements	9
Current status of type 1 (IgG4-related) autoimmune pancreatitis	9
Clinical practice advice on lifestyle modification in the management of nonalcoholic fatty liver disease in Japan: an expert review	8
Serum Mac2-binding protein glycosylated isomer (M2BPGi) as a prognostic biomarker in pancreatic ductal adenocarcinoma: iCAFs-derived M2BPGi drives tumor invasion	8
Change in systemic steroid use and surgery rate in patients with inflammatory bowel disease: a Japanese real-world database analysis	8
Global, regional, and national burden of liver cancer due to non-alcoholic steatohepatitis, 1990–2019: a decomposition and age–period–cohort analysis	8
Profile of plasma microRNAs as a potential biomarker of Wilson’s disease	8
Development of a capsule endoscopy scoring system for the early diagnosis of small bowel Crohn’s disease	8
Cost-effectiveness analysis of nivolumab plus chemotherapy vs chemotherapy for patients with unresectable advanced or metastatic HER2-negative gastric or gastroesophageal junction or esophageal adenoc	8
Correction to: Clinical guidelines for primary sclerosing cholangitis 2017	8
Partial splenic embolization combined with endoscopic therapies and vasoconstrictive drugs reduces rebleeding in cirrhosis patients with acute variceal bleeding and hypersplenism: a multicenter random	7
Publisher Correction: CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study	7
Serum FGF19 combined with GGT and other biomarkers predicted native liver survival following Kasai portoenterostomy in early biliary atresia	7
LncRNA n339260 functions in hepatocellular carcinoma progression via regulation of miRNA30e-5p/TP53INP1 expression	7
Correction: Current status and future perspective of linked color imaging for gastric cancer screening: a literature review	7
Impact of eradication of hepatitis C virus on liver-related and -unrelated diseases: morbidity and mortality of chronic hepatitis C after SVR	7
Correction to: Sorafenib as adjuvant therapy following radiofrequency ablation for recurrent hepatocellular carcinoma within Milan criteria: a multicenter analysis	7
A novel artificial intelligence-based endoscopic ultrasonography diagnostic system for diagnosing the invasion depth of early gastric cancer	7
Kindlin-2–miR-1258–TCF4 feedback loop promotes hepatocellular carcinoma invasion and metastasis	7
Administration of a standard dose of vonoprazan fumarate delays gastric emptying in Japanese healthy adults: a prospective clinical trial	7
Correction: Characteristics of adult patients newly diagnosed with Crohn’s disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn’s disease in Japan (iCRES	7
An integrative multi-omics analysis reveals a multi-analyte signature of pancreatic ductal adenocarcinoma in serum	7
Potential roles of gastroesophageal reflux in patients with superficial esophageal squamous cell carcinoma without major causative risk factors	7
Effects of luseogliflozin on suspected MASLD in patients with diabetes: a pooled meta-analysis of phase III clinical trials	7
Correction: LAT1 expression influences Paneth cell number and tumor development in ApcMin/+ mice	7
Utility of Mac-2 binding protein glycosylation isomer as an excellent biomarker for the prediction of liver fibrosis, activity, and hepatocellular carcinoma onset: an expert review	7
Prognostic role of detailed colorectal location and tumor molecular features: analyses of 13,101 colorectal cancer patients including 2994 early-onset cases	6
Red dichromatic imaging and linked color imaging as reliable image-enhanced endoscopic procedures for detecting the distal end of the palisade vessels in the columnar metaplastic mucosa of the gastroe	6
Impact of early aggressive treatment on long-term biochemical marker patterns in inflammatory bowel disease	6
Acknowledgements	6
Reply to ‘C-CAT's triumph in gastroenterology: the wisdom of cats is infinitely superior’	6
The interplay between alterations in esophageal microbiota associated with Th17 immune response and impaired LC20 phosphorylation in achalasia	6
Long-term evaluation of Helicobacter pylori screening in school health checkups: an 11-year study in Japan	6

Second primary malignancies in patients with clinical T1bN0 esophageal squamous cell carcinoma after definitive therapies: supplementary analysis of the JCOG trial: JCOG0502	6
Liver-related events after direct-acting antiviral therapy in patients with hepatitis C virus-associated cirrhosis	6
Dietary vitamin D intake and risk of colorectal cancer according to vitamin D receptor expression in tumors and their surrounding stroma	6
Pancreatic atrophy and recovery after allogeneic hematopoietic cell transplantation	6
CACNA2D1 regulates the progression and influences the microenvironment of colon cancer	6
The useful predictors of zinc deficiency for the management of chronic liver disease	6
Metformin use is not associated with reduced risk of older onset inflammatory bowel disease: a Danish nationwide population-based study	6
Ursodeoxycholic acid is associated with improved long-term outcome in patients with primary sclerosing cholangitis	6
Upregulation of BMI1-suppressor miRNAs (miR-200c, miR-203) during terminal differentiation of colon epithelial cells	6
Educational interventions to enhance support for balancing work and treatment in inflammatory bowel disease patients	6
A clinicopathological study of IgG4-related autoimmune hepatitis and IgG4-hepatopathy	6
Blockade of C5aR1 alleviates liver inflammation and fibrosis in a mouse model of NASH by regulating TLR4 signaling and macrophage polarization	6
The magnetic resonance imaging and age-adjusted matrix metalloproteinase-7 assist the diagnosis of biliary atresia	6
The clinical outcome from early versus delayed minimally invasive intervention for infected pancreatic necrosis: a systematic review and meta-analysis	6
Efficacy and safety of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma patients with esophageal–gastric varices	5
High-mobility group box 1: friend or foe in pancreatitis	5
Proportion of unresectable pancreatic cancer specimens obtained by endoscopic ultrasound-guided tissue acquisition meeting the OncoGuide™ NCC Oncopanel System analysis suitability criteria: a single-a	5
Letrozole ameliorates liver fibrosis through the inhibition of the CTGF pathway and 17β-hydroxysteroid dehydrogenase 13 expression	5
Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort	5
Real-world efficacy of antibiotic prophylaxis for upper gastrointestinal bleeding in cirrhotic patients in Japan	5
Gastrointestinal symptoms in COVID-19 and disease severity: a Japanese registry-based retrospective cohort study	5
Development and validation of a claims-based algorithm to identify incidents and determine the progression phases of gastric cancer cases in Japan	5
The impact of the age-adjusted Charlson comorbidity index as a prognostic factor for endoscopic papillectomy in ampullary tumors	5
Prognostic factors of second-line nivolumab monotherapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study for 184 cases	5
New chemiluminescent enzyme immunoassay for quantitative measurement of Mac-2 binding protein glycosylation isomer in chronic liver disease	5
Possibility of determining high quantitative fecal occult blood on stool surface using hyperspectral imaging	5
Genomic landscape and clinical features of rare subtypes of pancreatic cancer: analysis with the national database of Japan	5
Autoantibodies against endothelial protein C receptor and integrin αvβ6 predict the development of ulcerative colitis	5
Novel probiotic yeast from Miso promotes regulatory dendritic cell IL-10 production and attenuates DSS-induced colitis in mice	5
Determination of optimal cutoff value of ulcerative colitis intestinal ultrasound index to estimate endoscopic improvement in ulcerative colitis	5
Clinicopathological characteristics of colorectal serrated polyposis syndrome (SPS): results of a multicenter study by the SPS Study Group in Japan	5
A survey questionnaire evaluating physical activity patterns and determinants in patients with chronic liver disease	5
Nationwide survey for patients with acute-on-chronic liver failure occurring between 2017 and 2019 and diagnosed according to proposed Japanese criteria	5
Medical costs according to the stages of colorectal cancer: an analysis of health insurance claims in Hachioji, Japan	5
Importance of rectal over colon status in ulcerative colitis remission: the role of microinflammation and mucosal barrier dysfunction in relapse	5
iATT liver fat quantification for steatosis grading by referring to MRI proton density fat fraction: a multicenter study	5
The personality traits activity, self-reproach, and negative affect jointly predict clinical recurrence, depressive symptoms, and low quality of life in inflammatory bowel disease patients	5
Medical treatment selection and outcomes for hospitalized patients with severe ulcerative colitis as defined by the Japanese criteria	5
The clonal heterogeneity of colon cancer with liver metastases	5
Effect of tumor microenvironment in pancreatic cancer on the loss of β-cell mass: implications for type 3c diabetes	5
Validation of the Japanese version of the Esophageal Hypervigilance and Anxiety Scale for esophageal symptoms	4
Does early intervention for infected pancreatic necrosis lead to better clinical outcomes compared to delayed intervention?	4
Oral administration of d-serine prevents the onset and progression of colitis in mice	4
Diagnostic performance of attenuation imaging versus controlled attenuation parameter for hepatic steatosis with MRI-based proton density fat fraction as the reference standard: a prospective multicen	4
Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retros	4
Efficacy of liposomal irinotecan + 5-FU/LV vs. S-1 in gemcitabine-refractory metastatic pancreatic cancer: a real-world study using inverse probability of treatment weighting	4
Mortality and cancer in eosinophilic gastrointestinal disorders distal to the esophagus: nationwide cohort study 1990–2017	4
Anti-integrin αvβ6 autoantibody in primary sclerosing cholangitis: a Japanese nationwide study	4
Factors associated with the development of bacterial pneumonia and the preventive potential of peroral endoscopic myotomy in patients with esophageal motility disorders: a case–control study	4
Thiopurines exert harmful effects on spermatogenesis in Nudt15R138C knock-in mice	4
Liver transplantation for gastroenteropancreatic neuroendocrine liver metastasis: optimal patient selection and perioperative management in the era of multimodal treatments	4
Effect of gastric cancer screening on long-term survival of gastric cancer patients: results of Korean national cancer screening program	4
Correction: The association between antigenemia, histology with immunohistochemistry, and mucosal PCR in the diagnosis of ulcerative colitis with concomitant human cytomegalovirus infection	4
Identification of anti-Helicobacter pylori antibody signatures in gastric intestinal metaplasia	4
First-line biologics as a treatment for ulcerative colitis: a multicenter randomized control study	4
Cox proportional hazards regression reveals more than a 100-fold difference in cancer risk by the length of Barrett’s esophagus in Japan	4
Acid suppressants during hospitalization and after discharge in patients after gastroduodenal ESD	4
COVID-19-associated liver injury (COVALI): role of hepatologists	4
Medium-chain and long-chain fatty acids are associated with diarrheal predominant irritable bowel syndrome revealed by DESI-MSI	4
Resistant starch reduces glycolysis by HK2 and suppresses high-fructose corn syrup-induced colon tumorigenesis	4
A combination of liver stiffness and international normalized ratio is an ideal prognostic predictor of portosystemic shunt occlusion in patients with portal hypertension	4
Clinical impact of epithelial types on postoperative outcomes for intraductal papillary mucinous neoplasms: a multicenter retrospective study	4
Neutrophil gelatinase-associated lipocalin predicts the efficacy of tolvaptan for ascites in patients with liver cirrhosis	3
Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy	3
Systematic review and meta-analysis: analysis of variables influencing the interpretation of clinical trial results in NAFLD	3
Correlation of mucosal healing endpoints with long-term clinical and patient-reported outcomes in ulcerative colitis	3
Group 1 innate lymphoid cells and inflammatory macrophages exacerbate fibrosis in creeping fat through IFN-γ secretion	3
Minocycline vs. tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori rescue treatment: a multicentre, randomized controlled trial	3
Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy	3
Low HDL cholesterol levels in women and hypertriglyceridemia in men: predictors of MASLD onset in individuals without steatosis	3
Machine learning-based model for prediction and feature analysis of recurrence in pancreatic neuroendocrine tumors G1/G2	3
Smoking history and severe atrophic gastritis assessed by pepsinogen are risk factors for the prevalence of synchronous gastric cancers in patients with gastric endoscopic submucosal dissection: a mul	3
Reply to “Ferroptosis in the colon epithelial cells as a therapeutic target for ulcerative colitis”	3
Age distribution and risk factors for Barrett's esophagus by sex at health check-up settings in Japan	3
Nuclear magnetic resonance-based metabolomics and risk of pancreatic cancer: a prospective analysis in the UK Biobank	3
Postinfectious onset in functional dyspepsia is a risk factor for weight loss	3
Reply to “Acid suppressants during hospitalization and after discharge in patients after gastroduodenal ESD”	3
CircDCBLD2 alleviates liver fibrosis by regulating ferroptosis via facilitating STUB1-mediated PARK7 ubiquitination degradation	3
A combination of bowel wall thickness and submucosa index is useful for estimating endoscopic improvement in ulcerative colitis: external validation of the Kyorin Ultrasound Criterion	3
Amendment of the Japanese consensus guidelines for autoimmune pancreatitis, 2020	3
Inhibition of liver cancer cell growth by metabolites S-adenosylmethionine and nicotinic acid originating from liver progenitor cells	3
Management of colorectal high-grade dysplasia or cancer resected by cold snare polypectomy: a multicenter exploratory study	3
Current status and issues in genomic analysis using EUS-FNA/FNB specimens in hepatobiliary–pancreatic cancers	3
Predictive factors for subsequent intrahepatic cholangiocarcinoma associated with hepatolithiasis: Japanese National Cohort Study for 18 years	3
How to manage esophageal squamous cell carcinoma invading into the muscularis mucosa or submucosa after endoscopic resection	3
Comparing the predictive ability of portoatrial and portocaval gradient after transjugular intrahepatic portosystemic shunt creation for variceal rebleeding	3
Current status and future perspective of linked color imaging for gastric cancer screening: a literature review	3
Alcohol-associated liver disease increases the risk of muscle loss and mortality in patients with cirrhosis	3
A revolutionary oral HBV treatment candidate as innovative therapeutic approach warranting clinical trials	3
The role of sex hormones in the fecal microbiota of IBS-D patients with exacerbation of symptoms deserves attention	3
Tenofovir vs. entecavir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative resection	3
A comprehensive analysis of tumor-stromal collagen in relation to pathological, molecular, and immune characteristics and patient survival in pancreatic ductal adenocarcinoma	3